Lesion catalogue

Browse Atlas

Lesion / Benign non-odontogenic tumors

Osteoblastoma

Occurs in: maxilla, mandible. ORAD scores these locations as separate rows in the differential.

Updated 2026-07-27 Suggest an edit

Overview and definition

Osteoblastoma is a benign bone-forming neoplasm classified as an intermediate (locally aggressive) tumor in the 2020 WHO Classification of Soft Tissue and Bone Tumours.[1][2] It accounts for less than 1% of all primary bone tumors and most commonly involves the spine and long bones; gnathic involvement is uncommon, with fewer than 10% of osteoblastomas arising in the skull and approximately half of those affecting the jaws.[3][4] The tumor is driven by recurrent FOS (or, less commonly, FOSB) rearrangements, which are shared with osteoid osteoma and cementoblastoma.[5][6] On imaging, gnathic osteoblastoma characteristically presents as a mixed radiolucent–radiopaque mass with variable borders and no periosteal reaction.[3][7] Management centers on complete surgical excision, which is curative in most cases.[3][7]

Terminology and classification

Current Classification

The 2020 WHO classification lists osteoblastoma as a distinct entity within the osteogenic tumor category, classified as intermediate (locally aggressive).[1][2] It is separated from osteoid osteoma primarily by an arbitrary size threshold of 20 mm and by differing clinical and radiologic behavior, despite identical histology and shared FOS/FOSB molecular alterations.[1]

Accepted Names and Aliases

  • Osteoblastoma — standard term
  • Giant osteoid osteoma — historical synonym, now obsolete but occasionally encountered in older literature
  • Epithelioid osteoblastoma (synonym: aggressive osteoblastoma) — a recognized variant featuring large epithelioid osteoblasts; the 2020 WHO notes no evidence of worse prognosis compared with conventional osteoblastoma and recommends separating it from osteoblastoma-like osteosarcoma[8][9]
  • Toxic osteoblastoma — a rare clinical variant defined by systemic manifestations (fever, cachexia, diffuse periostitis) rather than distinct histology[10][11]

Obsolete or Misleading Terms

The terms "malignant osteoblastoma" and "pseudomalignant osteoblastoma" have been largely abandoned; tumors previously so designated are now reclassified as either epithelioid osteoblastoma or osteoblastoma-like osteosarcoma depending on histologic and molecular features.[8][12]

Epidemiology

  • Frequency in the jaws: Gnathic osteoblastoma is rare. Among nearly 20,000 oral pathology specimens in one 53-year retrospective series, bone-forming tumors (osteoma, osteoblastoma, osteosarcoma combined) constituted only 0.37% of diagnoses.[13]
  • Age: Most patients present in the second and third decades of life, though the reported range in gnathic cases spans 5 to 69 years.[3][4]
  • Sex: Slight male predominance (approximately 58% male in pooled jaw series; up to 2.5:1 male-to-female ratio in general skeletal series).[3][14]
  • Jaw distribution: The mandible is affected in approximately three-quarters of gnathic cases, with the posterior body and ramus being the most common subsites; maxillary involvement is considerably less frequent. Among maxillary cases, extension into the maxillary sinus and nasal cavity has been reported.[3][13][15][16]

Clinical presentation

Symptoms and Presentation

  • Pain is the most common presenting symptom, reported in approximately 78% of gnathic cases; unlike osteoid osteoma, the pain is typically dull, not characteristically nocturnal, and less reliably relieved by NSAIDs.[3][4]
  • Swelling is present in the vast majority of cases, manifesting as a firm, slowly progressive bony expansion.[3]
  • The overlying mucosa is typically intact without ulceration.[3]

Examination Findings

  • A hard, non-tender to mildly tender bony expansion is the characteristic finding on palpation.[3]
  • Tooth mobility and mucosal ulceration are uncommon.[3]
  • Paresthesia of the inferior alveolar nerve is not a typical feature, which helps distinguish osteoblastoma from malignant processes.[3]

Tempo and Complications

  • Growth is slow and progressive. Symptoms may precede diagnosis by months to years.[4]
  • Adjacent tooth roots are involved in a minority of cases; frank root resorption is rare.[3]
  • Secondary aneurysmal bone cyst change can occur, potentially causing rapid expansion and increased vascularity.[17][18]
  • The rare "toxic" variant presents with systemic features including fever, weight loss, anemia, and diffuse periostitis of uninvolved bones.[3][10][11]

Radiographic findings

Location and Distribution

Gnathic osteoblastoma arises most commonly in the posterior mandible (body, ramus, retromolar region).[3][7] Maxillary tumors are less frequent and may involve the alveolar process, maxillary sinus, or nasal cavity.[15][16] Periosteal (surface) presentation has been documented in the jaws; small periosteal tumors may be radiographically undetectable on conventional imaging.[7]

Periphery and Shape

  • Borders range from well-defined to poorly defined. A well-corticated sclerotic rim is characteristically absent, which distinguishes osteoblastoma from many other benign jaw lesions.[3][7]
  • The overall shape is typically round to ovoid and expansile.[16][19]
  • Periosteal reaction and perpendicular bone spiculation ("sunray" pattern) are characteristically absent; their presence should raise concern for osteosarcoma.[3]

Internal Architecture

  • The hallmark appearance is a mixed radiolucent–radiopaque pattern, reflecting variable degrees of osteoid and woven bone mineralization within the tumor.[3][7][13]
  • Internal calcifications may appear as coarse, clustered radiopaque foci ("radiopaque mottling") rather than the fine, granular calcifications typical of fibro-osseous lesions.[3][14]
  • Occasional tumors present as predominantly radiolucent, particularly in early or less mineralized stages; rarely, a homogeneously radiopaque appearance is seen.[7][16]
  • CBCT demonstrates the internal mineralization pattern and its three-dimensional distribution more reliably than panoramic radiography, particularly for maxillary lesions where superimposition limits conventional assessment.[20][21]

Effects on Teeth and Adjacent Structures

  • Displacement of adjacent teeth occurs occasionally.[3]
  • Root resorption is uncommon; in pooled gnathic data, root involvement was noted in approximately 29% of cases but frank resorption was documented in only a small minority.[3][22]
  • Loss of the lamina dura adjacent to the tumor may be observed.
  • In the mandible, the inferior alveolar canal may be displaced or its cortical outline effaced. In the maxilla, the tumor may extend into the maxillary sinus or nasal cavity with thinning or loss of the sinus floor.[15][16]

Cortical Involvement and Extent

  • Cortical expansion is common and is typically the feature that prompts clinical detection.[3][19]
  • Cortical thinning is frequent; frank cortical perforation can occur, particularly in larger or more aggressive tumors.[15][19]
  • CBCT is superior to panoramic radiography for evaluating cortical integrity, expansion, and the three-dimensional extent of the lesion.[20][21]

Variants and Atypical Appearances

  • Secondary aneurysmal bone cyst: Cystic, blood-filled spaces may develop within the tumor, producing fluid–fluid levels on cross-sectional imaging and a more aggressive radiographic appearance.[17][23]
  • Epithelioid (aggressive) osteoblastoma: Tends to be larger and may show more poorly defined margins on imaging, though the radiographic pattern remains mixed radiolucent–radiopaque.[23][24]
  • Periosteal osteoblastoma: Presents as a surface-based mass that may be subtle or invisible on panoramic radiography; cross-sectional imaging is essential for detection.[7]

Other imaging findings

Medical CT

CT is valuable for characterizing gnathic osteoblastoma when CBCT is insufficient or when the tumor extends beyond the dentoalveolar region. CT delineates the origin and full extent of the tumor, the presence and pattern of matrix mineralization, and the integrity of a thin bony shell at the tumor periphery more reliably than conventional radiography.[19] For maxillary tumors extending into the paranasal sinuses or skull base, contrast-enhanced CT helps define the relationship to critical structures.[16] Punctate or nodular calcifications within a lytic matrix and a complete or incomplete sclerotic rim are characteristic CT findings.[25]

MRI

MRI is useful for evaluating soft-tissue extension, marrow edema, and secondary aneurysmal bone cyst components.[19][26] Osteoblastoma typically shows low to intermediate signal on T1-weighted sequences and variable signal on T2-weighted sequences; areas of dense osteoid production may appear low signal on both sequences.[26][27] Gadolinium enhancement of the non-calcified tumor component is characteristic.[26][28] A key caveat is that MRI may overestimate lesion extent due to extensive peritumoral marrow and soft-tissue edema (the "flare phenomenon"), which can simulate malignancy.[25][29] CT more accurately reflects the true tumor boundaries and should be correlated with MRI findings.[29]

Differential diagnosis

Gnathic osteoblastoma presents a diagnostic challenge because of its rarity and its variable mixed radiolucent–radiopaque appearance, which overlaps with several fibro-osseous, odontogenic, and neoplastic entities. The critical distinction is from osteosarcoma, which demands histopathologic and often molecular confirmation.

EntityWhy it is consideredBest discriminator
Osteosarcoma (osteoblastic type)Mixed radiolucent–radiopaque jaw mass with bone destruction in a young patientOsteoblastoma lacks periosteal reaction, sunray spiculation, permeation of host bone, and lace-like osteoid; FOS rearrangement supports osteoblastoma[3][6][12]
CementoblastomaMixed-density mass intimately fused to a tooth root in the posterior mandibleCementoblastoma is inseparable from the root with characteristic radiolucent halo; osteoblastoma is not root-attached and is typically larger[3][30][31]
Ossifying fibromaWell-circumscribed mixed radiolucent–radiopaque mandibular lesion with downward bowing of the inferior cortexOssifying fibroma shows fine, granular calcifications and a well-defined corticated border, unlike the coarser mineralization and absent sclerotic rim of osteoblastoma[3]
Fibrous dysplasiaExpansile mixed-density lesion with ground-glass internal patternFibrous dysplasia is poorly circumscribed, blends with surrounding bone, may be multifocal, and shows GNAS mutation rather than FOS rearrangement[3][32]
Central giant cell granulomaExpansile radiolucent to mixed lesion of the anterior mandible or maxillaCentral giant cell granuloma favors the anterior jaws, may cross the midline, and typically appears multilocular with wispy septa; osteoblastoma favors the posterior mandible and shows denser internal mineralization[3]

The highest-risk diagnostic pitfall is misdiagnosis as osteosarcoma (leading to overtreatment) or, conversely, failure to exclude osteoblastoma-like osteosarcoma (leading to undertreatment). Incisional biopsy with adequate tissue for permanent sections is essential; frozen section is unreliable because bone fragments require decalcification.[3] In histologically ambiguous cases, FISH for FOS rearrangement and copy-number profiling can resolve the distinction: FOS/FOSB rearrangement with a flat copy-number profile supports osteoblastoma, whereas an unstable copy-number profile favors osteosarcoma.[6][8]

Histopathology

Microscopic Features

Osteoblastoma is composed of interconnecting trabeculae of woven bone and osteoid lined by a single layer of prominent, plump osteoblasts set within a richly vascularized fibrous stroma.[4][6] Scattered osteoclast-like giant cells and extravasated red blood cells are common.[14][18] The trabeculae are broader, longer, and less densely packed than those of osteoid osteoma, with more abundant intervening stroma.[18] Grossly, the tumor is tan-red and gritty; blood-tinged cystic areas are commonly present.[14]

Key Diagnostic Criteria

  • Circumscription: Osteoblastoma shows sharp delineation from adjacent host bone with peripheral maturation of trabeculae — a critical feature distinguishing it from osteosarcoma, which permeates and entraps preexisting lamellar bone.[3][8]
  • Absence of malignant features: No lace-like osteoid sheets, no cartilaginous differentiation, no atypical mitoses, and no permeation of surrounding bone.[3][8]
  • Mitotic activity may be present but atypical mitotic figures are absent in osteoblastoma.[8]

Variants

  • Epithelioid (aggressive) osteoblastoma: Features large, round epithelioid osteoblasts (at least twice the size of conventional osteoblasts) with eccentrically located nuclei, arranged in sheets or lining trabeculae. Despite the worrisome cytology, sharp delineation from host bone is maintained and prognosis is comparable to conventional osteoblastoma.[8][9][24]
  • Secondary aneurysmal bone cyst component: Blood-filled cystic spaces lacking USP6 rearrangement (distinguishing them from primary aneurysmal bone cyst).[17][33]

Molecular and Immunohistochemical Correlation

  • FOS (or rarely FOSB) rearrangement is present in 70–90% of osteoblastomas and can be detected by FISH. FOS immunohistochemistry shows diffuse strong staining in approximately 83% of osteoblastomas.[5][6][34]
  • Homozygous NF2 deletion is found in some fusion-negative cases.[6]
  • Cementoblastoma harbors the same FOS rearrangements, supporting the concept that gnathic osteoblastoma and cementoblastoma may represent a spectrum of the same disease.[6][31][35]
  • Detection of FOS/FOSB rearrangement with a flat (stable) copy-number profile supports osteoblastoma over osteoblastoma-like osteosarcoma, which shows genomic instability.[6][8]

Management and prognosis

Workup and Referral

Suspected gnathic osteoblastoma requires referral to an oral and maxillofacial surgeon with experience in jaw tumor management. Incisional biopsy with adequate tissue for permanent histologic sections is mandatory; frozen section is unreliable for bone-forming tumors.[3] In diagnostically challenging cases, FOS FISH and/or immunohistochemistry should be requested.[6][34]

Definitive Treatment

  • Conservative surgical excision (curettage or enucleation) is the standard treatment for conventional gnathic osteoblastoma.[3][7][14]
  • En bloc resection is indicated for large tumors, recurrent lesions, the epithelioid (aggressive) variant, or tumors in locations where curettage cannot achieve complete removal.[15][36][37]
  • Reconstruction of resultant jaw defects may require bone grafting, titanium implants, or free tissue transfer depending on defect size.[3][38]
  • Adjuvant radiation therapy is generally not recommended; it does not reliably prevent recurrence and carries a theoretical risk of radiation-induced malignant transformation.[39][40]

Recurrence and Surveillance

  • The recurrence rate for gnathic osteoblastoma is low, reported at approximately 14% in pooled jaw data, and is usually attributable to incomplete excision.[3]
  • In the largest general skeletal series (306 cases), recurrence rates of 16–21% were documented, with higher rates following curettage alone compared with en bloc resection.[41][42]
  • Aggressive (epithelioid) osteoblastomas in the general skeleton may recur in up to half of cases after intralesional surgery, though gnathic epithelioid osteoblastomas appear to follow a more favorable course.[9][43]
  • Recurrence typically occurs within the first 1–2 years but has been reported as late as 9 years after excision; long-term clinical and radiographic surveillance is therefore warranted.[16][39]

Prognosis

  • Overall prognosis is excellent. No patient in the largest gnathic series died of disease, and long-term disease-free survival (up to 25 years) has been documented after adequate excision.[3][7]
  • Malignant transformation is exceedingly rare and disputed; recent molecular evidence suggests that some reported cases may represent de novo osteoblastoma-like osteosarcoma rather than true transformation.[8][44]
ORAD reference data

Radiographic characteristics

18 characteristics

Banded distributions from the ORAD reference database.

Clinical Features

What is the sex of your patient? Male · commonly
What is the sex of your patient?
FindingFrequency
Male commonly
Female commonly
Unknown rarely
What is the race of your patient? Nonblack · usually
What is the race of your patient?
FindingFrequency
Black occasionally
Nonblack usually
Unknown rarely
What is the age of your patient? 11 - 25 · commonly
What is the age of your patient?
FindingFrequency
0 - 10 occasionally
11 - 25 commonly
26 - 50 sometimes
50 + rarely
Unknown rarely
Does your patient have pain or paresthesia? Pain · usually
Does your patient have pain or paresthesia?
FindingFrequency
Pain usually
No pain sometimes
Unknown rarely

Radiographic Features

Which jaw contains the lesion? Mandible only · usually
Which jaw contains the lesion?
FindingFrequency
Maxilla only sometimes
Mandible only usually
Both jaws not reported
The lesion center is in what region ? Molar region · commonly
The lesion center is in what region ?
FindingFrequency
Incisor region rarely
Canine/Premolar Region sometimes
Molar region commonly
Ramus region occasionally
TMJ region rarely
Sinus region sometimes
The relationship of the lesion to teeth is: Not tooth associated · usually
The relationship of the lesion to teeth is:
FindingFrequency
Crown associated not reported
Root associated occasionally
Apex associated occasionally
Missing tooth associated sometimes
Not tooth associated usually
Is the tooth associated with the lesion vital? Vital · usually
Is the tooth associated with the lesion vital?
FindingFrequency
Vital usually
Not vital rarely
Unknown rarely
Please estimate the number of lesions: One · usually
Please estimate the number of lesions:
FindingFrequency
One usually
Two not reported
Three or more not reported
Generalized not reported
What is the maximum size of the lesion? 2 to 3 cm · commonly
What is the maximum size of the lesion?
FindingFrequency
Less than 2 cm occasionally
2 to 3 cm commonly
Greater than 3 cm commonly
Where is the origin of the lesion? Central · usually
Where is the origin of the lesion?
FindingFrequency
Central usually
Peripheral sometimes
The borders of the lesion are: Defined but not corticated · commonly
The borders of the lesion are:
FindingFrequency
Corticated occasionally
Defined but not corticated commonly
Diffuse sometimes
The loculation of the lesion is: Not loculated · usually
The loculation of the lesion is:
FindingFrequency
Unilocular sometimes
Multilocular not reported
Not loculated usually
The contents of the lesions are: Mixed · usually
The contents of the lesions are:
FindingFrequency
Radiolucent occasionally
Radiopaque rarely
Mixed usually
Radiolucent with flecks sometimes
Does the lesion contain one or more teeth ? No · usually
Does the lesion contain one or more teeth ?
FindingFrequency
Yes occasionally
No usually
Unknown occasionally
Does the lesion expand the bony cortex? Yes · usually
Does the lesion expand the bony cortex?
FindingFrequency
Yes usually
No occasionally
Does the lesion cause root resorption ? No · usually
Does the lesion cause root resorption ?
FindingFrequency
Yes occasionally
No usually
Does the lesion cause tooth displacement or impaction? No · usually
Does the lesion cause tooth displacement or impaction?
FindingFrequency
Yes sometimes
No usually
Atlas sources

References

44 sources
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
    Osteoblastoma of the Mandible With Root Resorption: A Case Report. Oztürk M, Ozeç I, Aker H, Müslehiddinoğlu A. Quintessence International (Berlin, Germany : 1985). 2003;34(2):135-8.
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
    Cemento-Ossifying Fibroma and Benign Cementoblastoma. El-Mofty SK. Seminars in Diagnostic Pathology. 1999;16(4):302-7.
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
    Osteoblastoma of the Jaw: Report of Two Cases and Review of the Literature. Angiero F, Mellone P, Baldi A, Stefani M. In Vivo (Athens, Greece). 2006 Sep-Oct;20(5):665-70.
  38. 38
  39. 39
    Recurrent Osteoblastoma: A Review. Jackson RP. Clinical Orthopaedics and Related Research. 1978 Mar-Apr;(131):229-33.
  40. 40
    Benign Osteoblastoma: Range of Manifestations. Marsh BW, Bonfiglio M, Brady LP, Enneking WF. The Journal of Bone and Joint Surgery. American Volume. 1975;57(1):1-9.
  41. 41
  42. 42
  43. 43
  44. 44

Build an interactive differential →

Nearest neighbours

Expand to full map ↗

This lesion (ringed) among its most radiographically similar entries. Region and origin must overlap, so every neighbour is a genuine differential.

Drag to explore · Ctrl/⌘ + scroll to zoom · click a neighbour to recentre

← All lesions